P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting. - Lago, N. Martínez; Lopez, B. Carnero; Gomez, J. De la Cámara; Vázquez-Rivera, F.; Montes, A. Fernández; Dios, N. de; Maseda, A. Carral; Augusto, M. Pellón; Folgar, S. Candamio; Reboredo-Lopez, M.; Fernandez, M. Salgado; Martin, E. Gallardo; et al. (Annals of Oncology, 2020)